Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611797200 on March 31, 2007

J. Biol. Chem., Vol. 282, Issue 21, 15484-15489, May 25, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/21/15484    most recent
M611797200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckstead, J. A.
Right arrow Articles by Ryan, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckstead, J. A.
Right arrow Articles by Ryan, R. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The C Terminus of Apolipoprotein A-V Modulates Lipid-binding Activity*

Jennifer A. Beckstead{ddagger}, Kasuen Wong{ddagger}§, Vinita Gupta{ddagger}, Chung-Ping L. Wan, Victoria R. Cook||, Richard B. Weinberg||**, Paul M. M. Weers, and Robert O. Ryan{ddagger}§1

From the {ddagger}Center for Prevention of Obesity, Diabetes, and Cardiovascular Disease, Children's Hospital Oakland Research Institute, Oakland, California 94609, §Department of Nutritional Sciences and Toxicology, University of California, Berkeley, California 94720, Department of Chemistry and Biochemistry, California State University, Long Beach, California 90840, Departments of ||Internal Medicine and **Physiology and Pharmacology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157

Human apolipoprotein A-V (apoA-V) is a potent modulator of plasma triacylglycerol (TG) levels. To probe different regions of this 343-amino-acid protein, four single Trp apoA-V variants were prepared. The variant with a Trp at position 325, distal to the tetraproline sequence at residues 293–296, displayed an 11-nm blue shift in wavelength of maximum fluorescence emission upon lipid association. To evaluate the structural and functional role of this C-terminal segment, a truncated apoA-V comprising amino acids 1–292 was generated. Far UV circular dichroism spectra of full-length apoA-V and apoA-V-(1–292) were similar, with ~50% {alpha}-helix content. In guanidine HCl denaturation experiments, both full-length and truncated apoA-V yielded biphasic profiles consistent with the presence of two structural domains. The denaturation profile of the lower stability component (but not the higher stability component) was affected by truncation. Truncated apoA-V displayed an attenuated ability to solubilize L-{alpha}-dimyristoylphosphatidylcholine phospholipid vesicles compared with full-length apoA-V, whereas a peptide corresponding to the deleted C-terminal segment displayed markedly enhanced kinetics. The data support the concept that the C-terminal region is not required for apoA-V to adopt a folded protein structure, yet functions to modulate apoA-V lipid-binding activity; therefore, this concept may be relevant to the mechanism whereby apoA-V influences plasma TG levels.


Received for publication, December 26, 2006 , and in revised form, March 2, 2007.

* This work was supported by National Institutes of Health Grants HL 73061 (to R. O. R.), HL 077135 (to P. M. M. W.), and HL 30897 (to R. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: CHORI, 5700 Martin Luther King Jr. Way, Oakland, CA 94609. Tel.: 510-450-7645; Fax: 510-450-7910; E-mail: rryan{at}chori.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T. M. Forte, X. Shu, and R. O. Ryan
The ins (cell) and outs (plasma) of apolipoprotein A-V
J. Lipid Res., April 1, 2009; 50(Supplement): S150 - S155.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X. Shu, R. O. Ryan, and T. M. Forte
Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment
J. Lipid Res., August 1, 2008; 49(8): 1670 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Nelbach, X. Shu, R. J. Konrad, R. O. Ryan, and T. M. Forte
Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice
J. Lipid Res., March 1, 2008; 49(3): 572 - 580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement